Brief: Qlife And Hipro Advance Heart Failure Tests Into Clinical Trials
15/09/2025 07:32
Sept 15 (Reuters) - Qlife Holding AB QLIFE.ST: QLIFE AND HIPRO ADVANCE HEART FAILURE TESTS INTO CLINICAL TRIALS Source text: ID:nWkr5VzbnV Further company coverage: QLIFE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Qlife Holding AB
See all newsAdvisory: Alerts on Qlife's agreement with global pharma company withdrawn
Brief: Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker
Brief: Qlife Holding Q1 EBITDA Loss SEK 5.5 Mln
Sweden's Qlife Q1 revenue drops, losses widen slightly
Brief: Qlife Holding Q4 EBITDA At SEK -1.6 Million